Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Pentrexyl Forte Natural: Recall - Misleading Packaging

May 23, 2011 10:30 am | by U.S. Food & Drug Administration | News | Comments

Dietary supplement product packaging may cause it to be confused with an antibiotic product.

FDA Schedules Advisory Committee Meeting to Discuss BLA for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration

May 23, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y. May 23, 2011 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today announced that the U.S. Food and Drug Administration (FDA) has informed the company that it has scheduled a Dermatologic and Ophthalmic Drugs Advisory Committee Meeting to be held on June 17, 2011 to...

Heska to Present at SunTrust Robinson Humphrey's Annual Veterinary and Dental Conference

May 23, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

LOVELAND, Colo., May 23, 2011 /- Heska Corporation (NASDAQ: HSKA ) today announced it will present at the SunTrust Robinson Humphrey Annual Veterinary and Dental Conference on Wednesday, June 1, 2011.  The presentation will be at the Le Parker Meridien Hotel at 119 West 56th Street...

Advertisement

Class I Medical Device Recall: Beckman Coulter, Inc., Synchron LX Clinical Systems Ion Selective Electrolyte (ISE) Flow Cell

May 23, 2011 9:30 am | by U.S. Food & Drug Administration | News | Comments

Reason for Recall: There may be ratio pump wear, silver iodide build-up on the chloride electrode, microbial contamination, general non-ISE hardware, and maintenance in the instruments (ion selective electrolyte flow cell) which may cause incorrect...

Use of TIGR® Matrix Surgical Mesh in Multi-Center Randomized Controlled TRAM Flap Study Passes 20 Patient Mark and Wins Praise from Participating Surgeons

May 23, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

SINGAPORE, May 23, 2011 /- Singapore company Novus Scientific Pte. Ltd announced that the TRAM Flap study (Abdominal Wall Closure After Lipectomy, TRAM/DIEP Flap - Comparison of TIGR® (100% Resorbable) vs Polypropylene (Permanent) Mesh) has passed the 20 patient mark, representing...

AACR Calls for Letters of Intent for a Stand Up To Cancer-Melanoma Research Alliance Dream Team

May 23, 2011 8:33 am | by AACR | News | Comments

Tweet PHILADELPHIA - Stand Up To Cancer (SU2C) and the Melanoma Research Alliance (MRA), along with the American Association for Cancer Research, call upon the cancer research community to submit Letters of Intent for a new Dream Team dedicated to melanoma research. The SU2C-MRA Melanoma...

Florida Hospital First U.S. Site to Adopt New Automated Laboratory Solution From Roche

May 23, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla., May 23, 2011 /- Florida Hospital is improving its laboratory testing capabilities with new state-of-the-art equipment from Roche Diagnostics that is designed to help labs increase their testing capacity and deliver reliable results with greater efficiency. The high-volume,...

Siemens Honored by Department of Defense Agency for Supporting Massachusetts Guardsman

May 23, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

NORWOOD, Mass., May, 23, 2011 /- The Norwood, Massachusetts facility of Siemens Healthcare Diagnostics (NYSE: SI ) was honored today with a 'Patriot Award' and an 'Above and Beyond Award' from the Employer Support of the Guard and Reserve (ESGR), a Department of Defense agency. Both...

Advertisement

Ultrafast Laser for Deep Tissue Imaging

May 23, 2011 7:16 am | Spectra-Physics | Product Releases | Comments

Spectra-Physics, a Newport Corporation brand, introduces InSight DeepSee, an extraordinary new ultrafast laser system that takes multiphoton imaging to new depths.

Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement

May 23, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, May 23, 2011 /- Eli Lilly and Company (NYSE: LLY ) today announced that it has signed agreements with private investors Care Capital and NovaQuest Capital to establish BioCritica Inc., a newly-formed and privately-held biotechnology company. BioCritica, based in Central...

Texas Instruments introduces first quad-channel 16-bit, 100 MSPS ADC for faster, smaller medical imaging equipment

May 23, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

DALLAS, May 23, 2011 /- Texas Instruments Incorporated (TI) (NYSE: TXN ) today introduced the first quad-channel, 16-bit analog-to-digital converter (ADC) for medical imaging applications, such as magnetic resonance imaging (MRI). The ADS5263 meets designers' needs for clear, crisp...

CardioGenics to Present at the 7th Annual Spring Growth Stock Conference Hosted by Security Research Associates, Inc.

May 23, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, May 23, 2011 /- CardioGenics Holdings Inc. (CGNH: OTCB) announced today that Dr. Yahia Gawad, CEO of CardioGenics will be presenting at the 7th Annual Spring Growth Stock Conference hosted by Security Research Associates, Inc.  The conference will be held on...

Aethlon Medical to Present the Aethlon ADAPTâ„¢ System at C21 BioVenturesâ„¢ Life Sciences Partnering Conference

May 23, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 23, 2011 / PRNewswire / -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announces that Chairman and CEO James A. Joyce will present the Aethlon ADAPT™ system in a...

Advertisement

Your Wireless Healthcare Provided By PulseOximetersPlus

May 23, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., May 23, 2011 /- The healthcare and computing industries rely heavily on mobility. For the past decade, the healthcare industry has been adopting new technologies allowing medical professionals and patients to be more mobile. New medical devices strive to meet these...

CardioMEMS Founder Dr. Jay Yadav Honored With Health-Care Heroes Award by the Atlanta Business Chronicle

May 23, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

ATLANTA, May 23, 2011 /- CardioMEMS, Inc ., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that its founder and CEO, Jay Yadav, M.D., was presented with a...

FDA approves Incivek for hepatitis C

May 23, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., May 23, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Incivek (telaprevir) to treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for...

Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Reduction in Clinical Events in Patients for 18 Months Compar...

May 23, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Wash., May 23, 2011 /- Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 18-month data from its Phase 2 CUPID clinical trial of MYDICAR® demonstrated continued...

Covidien Launches Conscientious Collaboration Compliance Resource for Healthcare Professionals

May 23, 2011 3:36 am | by Covidien | News | Comments

DUBLIN, May 23, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of Conscientious Collaboration,an online resource to promote the importance of ethical and clinically meaningful collaboration between healthcare...

Isis Pharmaceuticals to Present a General Corporate Update at Its 2011 Annual Meeting of Stockholders and Open House

May 23, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., May 23, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a general corporate update in conjunction with its 2011 Annual Meeting of Stockholders and Open House on Thursday, June 16 at...

Pacira Pharmaceuticals, Inc. Announces EXPARELâ„¢ Data Presentations at the International Anesthesia Research Society 2011 Annual Meeting

May 23, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., May 23, 2011 /- Pacira Pharmaceuticals, Inc., (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced that clinical data highlighting the safety profile of EXPAREL™ (bupivacaine extended-release liposome injection) will be presented at the...

Mylan Launches Generic Version of Depakote® Sprinkle Capsules

May 23, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, May 23, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Divalproex Sodium Capsules USP, 125 mg, the generic version of Abbott's Depakote® Sprinkle Capsules, a treatment for certain types of seizures.  ...

Reportlinker Adds Advanced Digital Medical Equipment Products Market

May 23, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 23, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Advanced Digital Medical Equipment Products Market http://www.reportlinker.com/p0507254/Advanced-Digital-Medical-Equipment-Products-Market...

PAREXEL International to Present at Goldman Sachs Healthcare Conference and Jefferies Global Healthcare Conference

May 23, 2011 2:34 am | by Bio-Medicine.Org | News | Comments

BOSTON, May 23, 2011 /- PAREXEL International Corporation (NASDAQ: PRXL ) announced today that it will be presenting at the Goldman Sachs Healthcare Conference in Palos Verdes, CA.  Josef von Rickenbach, Chairman and Chief Executive Officer will be making a presentation on PAREXEL at...

Boston Healthcare Acquires Alpha Care GmbH, Expanding Health Economics, Pricing and Reimbursement Consulting Presence in Europe

May 23, 2011 2:32 am | by Bio-Medicine.Org | News | Comments

BOSTON and BERLIN, May 23, 2011 /- Boston Healthcare announced today that it has acquired Alpha Care GmbH, a consulting firm based in Germany that provides health economics and policy solutions for pharmaceutical, medical device, payer and provider organizations. Through this acquisition,...

Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur of the Year® San Diego Finalist

May 23, 2011 2:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 23, 2011 /- Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today that James Slattery , CEO and founder, is a regional finalist for the Ernst & Young Entrepreneur of the Year®...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading